Marshall Wace, LLP Haemonetics Corp Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

A detailed history of Marshall Wace, LLP transactions in Haemonetics Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 222,881 shares of HAE stock, worth $17.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
222,881
Previous 44,892 396.48%
Holding current value
$17.1 Million
Previous $3.71 Million 382.41%
% of portfolio
0.02%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$72.45 - $91.58 $12.9 Million - $16.3 Million
177,989 Added 396.48%
222,881 $17.9 Million
Q2 2024

Aug 14, 2024
SELL
$81.24 - $97.37 $2.97 Million - $3.55 Million
-36,503 Reduced 44.85%
44,892 $3.71 Million
Q1 2024

May 15, 2024
BUY
$71.24 - $85.35 $1.92 Million - $2.31 Million
27,018 Added 49.69%
81,395 $6.95 Million
Q4 2023

Feb 14, 2024
BUY
$80.59 - $92.61 $2.62 Million - $3.01 Million
32,529 Added 148.89%
54,377 $4.65 Million
Q3 2023

Nov 14, 2023
SELL
$82.56 - $93.49 $4.2 Million - $4.76 Million
-50,905 Reduced 69.97%
21,848 $1.96 Million
Q2 2023

Aug 14, 2023
BUY
$80.84 - $89.45 $5.88 Million - $6.51 Million
72,753 New
72,753 $6.19 Million
Q1 2022

May 16, 2022
SELL
$43.77 - $63.22 $4.53 Million - $6.55 Million
-103,583 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$49.55 - $74.59 $5.13 Million - $7.73 Million
103,583 New
103,583 $5.49 Million
Q1 2021

May 17, 2021
SELL
$111.01 - $139.48 $1.16 Million - $1.46 Million
-10,459 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$88.75 - $119.95 $6.79 Million - $9.17 Million
-76,452 Reduced 87.97%
10,459 $1.24 Million
Q3 2020

Nov 16, 2020
BUY
$75.65 - $93.58 $3.69 Million - $4.56 Million
48,779 Added 127.92%
86,911 $7.58 Million
Q2 2020

Aug 13, 2020
BUY
$84.96 - $118.91 $3.24 Million - $4.53 Million
38,132 New
38,132 $3.42 Million
Q1 2020

May 15, 2020
SELL
$74.34 - $121.82 $266,360 - $436,481
-3,583 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$114.37 - $129.46 $409,787 - $463,855
3,583 New
3,583 $412,000
Q3 2019

Nov 14, 2019
SELL
$117.16 - $138.52 $17.9 Million - $21.1 Million
-152,363 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$81.74 - $120.34 $8.37 Million - $12.3 Million
102,384 Added 204.85%
152,363 $18.3 Million
Q1 2019

May 14, 2019
BUY
$83.25 - $102.12 $4.16 Million - $5.1 Million
49,979 New
49,979 $4.37 Million
Q3 2018

Nov 14, 2018
SELL
$89.96 - $114.58 $203,219 - $258,836
-2,259 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$71.53 - $95.75 $53,933 - $72,195
-754 Reduced 25.02%
2,259 $203,000
Q1 2018

May 15, 2018
BUY
$60.72 - $74.41 $182,949 - $224,197
3,013 New
3,013 $220,000

Others Institutions Holding HAE

# of Institutions
332
Shares Held
53.8M
Call Options Held
689K
Put Options Held
345K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.93B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email